Zhejiang University School of Medicine Researcher Discusses Research in Liver Cancer (Adjuvant TACE plus lenvatinib as compared with TACE alone in patients with hepatocellular carcinoma at high risk of recurrence after surgery: A prospective ...)

Press/Media: Press / Media

PeriodFeb 7 2024

Media coverage

1

Media coverage

  • TitleZhejiang University School of Medicine Researcher Discusses Research in Liver Cancer (Adjuvant TACE plus lenvatinib as compared with TACE alone in patients with hepatocellular carcinoma at high risk of recurrence after surgery: A prospective ...)
    Media name/outletDisease Prevention Daily
    Country/TerritoryUnited States
    Date02/7/24
    PersonsBin Zhang